Skip to main content

l-5-Hydroxytryptophan in the Prophylaxis of Chronic Tension-type Headache: A Double-Blind, Randomized, Placebo-Controlled Study

Buy Article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

A parallel, randomized, double-blind trial is reported, in which 78 patients with chronic tension-type headaches were treated with l-5-hydroxytryptophan (5-HTP) (n = 43) or placebo (n = 35) for 8 weeks, after a washout period of 2 weeks and with a follow-up period of a further 2 weeks. Five patients dropped out (1 with placebo and 4 with 5-HTP), 1 was excluded due to noncompliance, and in 7 treatment was suspended due to adverse events (3 with placebo and 4 with 5-HTP), yielding a final number for evaluation of 65 patients. In comparison with the group treated with placebo, there was no statistically significant change in the number of days with headache or in headache intensity in the group treated with 5-HTP, 300 mg per day; however, there was a significant decrease in the consumption of analgesics. During the 2 weeks after treatment, there was a significant decrease in the number of days with headache. Subjective opinion during this latter period was also favorable to 5-HTP.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: 5-HT; chronic tension-type headache; controlled trial; l-5-hydroxytryptophan; preventive treatment

Document Type: Research Article

Publication date: 2000-06-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more